@gbg.deWhat does a flamingo have to do with breast cancer research? More than you might think!
The #Flamingo-01 trial (#GBG111) is investigating an immunological treatment approach for patients with #HER2/neu-positive breast cancer and an increased risk of #recurrence.
@healthcare-europe.bsky.social#AI enabled spatial analysis can identify patterns in routine #pathology slides that may help clinicians identify which patients with #pancreaticcancer are at greater risk of #recurrence after treatment and surgery, a new study finds.